An ovarian hyperstimulation syndrome caused by gonadotropinoma in a young woman

• Published in: Problemy endokrinologii Vol. 65; no. 4; p. 278
• Main Authors: Gorbacheva, A M, Przhiyalkovskaya, E G, Azizyan, V N, Stanoevich, I V, Grigoriev, A Y, Sazonova, A I, Lapshina, A M, Belaya, Z E
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 25.12.2019
• Subjects: pituitary neoplasms; ovarian hyperstimulation symdrome; follicle stimulating hormone
• ISSN: 2308-1430

From 14 to 54% of all pituitary adenomas are nonfunctioning pituitary adenomas (NPAs), their prevalence is estimated as 7.041.3 cases per 100 000 population. The most common type of NPAs (73% of cases) are gonadotropinomas. In most cases, gonadotropinoma is characterized by secretion of biologically inactive hormones, so the release of gonadotropins does not lead to the development of any clinical symptoms. For this reason the diagnosis of gonadotropinomas is most often performed on the basis of immunohistochemical analysis. However, in rare cases, gonadotropinomas secrete biologically active hormones, most often follicle-stimulating (FSH). Ovarian hyperstimulation syndrome due to gonadotropin-secreting pituitary tumors occurs in about 3% of women with hormonally inactive pituitary adenomas at reproductive age and in 8% of patients with verified gonadotropinomas. This clinical case describes a young patient with a rare pathology: FSH/LH-secreting macroadenoma of the pituitary, which led to the development of ovary hyperstymulation symdrome. The diagnosis of pituitary adenoma was performed due to the identified hyperprolactinemia one month before the development of visual impairment, which can be considered a late diagnosis. Surgical treatment of gonadotropinomy was carried out successfully and without complications, remission of the disease was achieved, visual function was restored, the patient successfully became pregnant.